{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-109285","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.998713+00:00","generated_at":"2026-05-29T03:05:56.657815+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Estrella Immunopharma regains compliance with both Nasdaq listing requirements","bullets":["Regained compliance with Stockholders' Equity Requirement after market value of listed securities exceeded $35M for 10 consecutive days ending Dec 10, 2024.","Regained compliance with Minimum Bid Price Requirement after closing bid price of common stock stayed at $1.00+ for 10 consecutive days ending Dec 10, 2024.","Both Nasdaq deficiency matters are now closed; no further action required."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-109285","json":"https://secwatch.observer/filing/0001213900-24-109285.json","markdown":"https://secwatch.observer/filing/0001213900-24-109285.md","text":"https://secwatch.observer/filing/0001213900-24-109285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/0001213900-24-109285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/ea0224902-8k_estella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:05:56.657815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}